Citation Impact
Citing Papers
Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade
2008
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Humanization of an anti-p185HER2 antibody for human cancer therapy.
1992
Development trends for monoclonal antibody cancer therapeutics
2007
A protein structural change in aglycosylated IgG3 correlates with loss of huFcγR1 and hufcγR111 binding and/or activation
1990
Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains
1991 StandoutNobel
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma
2008
Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways
1997
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
1993 Standout
Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli
1989 StandoutNatureNobel
Clinical Development of the Anti–CTLA-4 Antibody Tremelimumab
2010
The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose
2006
Site-Specific Glycosylation of an Aglycosylated Human IgG1-Fc Antibody Protein Generates Neoglycoproteins with Enhanced Function
2003
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Retargeting serum immunoglobulin with bispecific diabodies
1997 StandoutNobel
Heterogeneity in the ability of IgG1 monoclonal anti‐D to promote lymphocyte‐mediated red cell lysis
1989
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
2007 StandoutNatureNobel
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Man-made antibodies
1991 NatureNobel
Quantitative DNA hybridization in solution using magnetic/luminescent core–shell nanoparticles
2007
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
2021
IgG4-Related Disease
2012 Standout
Antibody framework residues affecting the conformation of the hypervariable loops
1992 StandoutNobel
Reshaping a Human Monoclonal Antibody to Inhibit Human Respiratory Syncytial Virus Infection in Vivo
1991
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors
1996
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The rapid detection of unknown mutations in nucleic acids
1993
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
The Pathogenic Effect of IgG4 Autoantibodies in Endemic Pemphigus Foliaceus (Fogo Selvagem)
1989
Combinatorial infection andin vivorecombination: a strategy for making large phage antibody repertoires
1993 StandoutNobel
Human antibody–Fc receptor interactions illuminated by crystal structures
2004
Building Antibodies from their Genes
1992 StandoutNobel
Macrophages are critical effectors of antibody therapies for cancer
2015
Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.
1992 StandoutNobel
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Retroviral vectors displaying functional antibody fragments
1993 StandoutNobel
Phage antibodies: filamentous phage displaying antibody variable domains
1990 StandoutNatureNobel
The Multichain Interleukin-2 Receptor: A Target for Immunotherapy
1992
Rheumatoid Factor Autoantibodies in Health and Diseasea
1997
Squamous cell carcinoma of the skin (excluding lip and oral mucosa)
1992
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
The structural requirements for complement activation by IgG: does it hinge on the hinge?
1995
Humanized Antibodies as Potential Therapeutic Drugs
1998
Monoclonal-Antibody Therapy in Systemic Vasculitis
1990
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Phage libraries for generation of clinically useful antibodies
1994 StandoutNobel
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
2001 Standout
Making antibody fragments using phage display libraries
1991 StandoutNatureNobel
REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
1988
In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells
1992 StandoutNobel
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Molecular Basis of Fc Receptor Function
1994
Adapting antibodies for clinical use.
1992
Generation of Lymphohematopoietic Cells from Embryonic Stem Cells in Culture
1994 StandoutScienceNobel
Tremelimumab (CP-675,206), a Cytotoxic T Lymphocyte–Associated Antigen 4 Blocking Monoclonal Antibody in Clinical Development for Patients with Cancer
2007
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.
1993
A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q
1994 StandoutNobel
Refined Structure of an Intact IgG2a Monoclonal Antibody,
1997
A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins
1990
The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
1995
Isolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning.
1988
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Role of CD47 as a Marker of Self on Red Blood Cells
2000 StandoutScience
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Alymphoplasia (aly)-Type Nuclear Factor κB–Inducing Kinase (Nik) Causes Defects in Secondary Lymphoid Tissue Chemokine Receptor Signaling and Homing of Peritoneal Cells to the Gut-Associated Lymphatic Tissue System
2000 StandoutNobel
"Diabodies": small bivalent and bispecific antibody fragments.
1993 StandoutNobel
Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-β receptor–IgG1 fusion protein
1996
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Lanthanide-Based Luminescent Hybrid Materials
2009 Standout
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
A repertoire of monoclonal antibodies with human heavy chains from transgenic mice.
1989
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III
2000 StandoutNobel
The immunogenicity of chimeric antibodies.
1989 StandoutNobel
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system.
1992 StandoutNobel
Monoclonal Antibodies in Diagnosis and Therapy
1991 Science
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Works of M R Walker being referenced
Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population
1991
Sequencing of PCR-amplified DNA.
1992
Interaction of human IgG chimeric antibodies with the human FcRI and FcRII receptors: Requirements for antibody-mediated host cell-target cell interaction
1989
Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG.
1991
Restricted light chain subgroup expression on human rheumatoid factor paraproteins determined by monoclonal antibodies.
1986
Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing FcγRI and/or FcγRII receptors
1989
Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
1989
Synthesis in vitro and application of biotinylated DNA probes for human papilloma virus type 16 by utilizing the polymerase chain reaction
1990
Immobilization of polynucleotides on magnetic particles. Factors influencing hybridization efficiency
1991
Immunogenic and antigenic epitopes of immunoglobulins. XIV. Antigenic variants of IgG4 proteins revealed with monoclonal antibodies.
1986
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.
1987